# Exploring the PK of Different Doses of Naltrexone in Patients With AUD

> **NCT05919017** · PHASE1 · UNKNOWN · sponsor: **Shenzhen Sciencare Medical Industries Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- AUD

## Interventions

- **DRUG:** Naltrexone implant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05919017
- **Lead sponsor:** Shenzhen Sciencare Medical Industries Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-16
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-05-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05919017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05919017, "Exploring the PK of Different Doses of Naltrexone in Patients With AUD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05919017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*